CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

Explore the PTAB proceeding IPR2023-00724 filed by Mylan Pharmaceuticals Inc. et al. on 2023-03-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00724

Filing Date

2023-03-16

Accorded Filing Date

2023-03-16

Institution Decision Date

2023-10-04

Last Modified Date

2025-03-07

Proceeding Type

IPR

Termination Date

2025-01-10

Trial Status

Terminated-Settled

Parties & Counsel

Patent Owner / Respondent

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved
Respondent Application Number 15656042
Respondent Patent Number 10335462
Respondent Inventor Christine Bjoern Jensen
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

5 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name NOVO NORDISK INC. - INTELLECTUAL PROPERTY DEPARTMENT
Customer Number 23650
Address 800 Scudders Mill Road, Plainsboro, NJ, 08536, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
56129 Wesley Nicolas 609-786-5418
62124 Leon Lum 609-786-4172
63996 Elizabeth Dingess-Hammond 317-433-3689
64519 Jianjie Hu 609-786-4129
74995 Kathryn Jones 804-426-7196

Proceeding Documents

200
122

Order: Granting PO's Motion to Expunge ORDER

2025-03-07 FILING PARTY: BOARD
121

Patent Owner's Motion to Expunge OTHER

2025-02-11 FILING PARTY: PATENT OWNER
118

Termination Decision: Post-DI Settlement TERMINATE

2025-01-10 FILING PARTY: BOARD
119

Order: Order on Motions to Expunge ORDER

2025-01-10 FILING PARTY: BOARD
120

Order: On Protective Orders and Motions to Seal ORDER

2025-01-10 FILING PARTY: BOARD